Indexed In : Science Citation Index Expanded(SCIE), MEDLINE,
Pubmed/Pubmed Central, Elsevier Bibliographic, Google Scholar,
Databases(Scopus & Embase), KCI, KoreaMed, DOAJ
Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE
Yong Chan Lee |
Professor of Medicine Director, Gastrointestinal Research Laboratory Veterans Affairs Medical Center, Univ. California San Francisco San Francisco, USA |
Jong Pil Im | Seoul National University College of Medicine, Seoul, Korea |
Robert S. Bresalier | University of Texas M. D. Anderson Cancer Center, Houston, USA |
Steven H. Itzkowitz | Mount Sinai Medical Center, NY, USA |
All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.
The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.
Jae Gon Lee1 , In Kyung Yoo2 , Abdullah Ozgur Yeniova3 , Sang Pyo Lee1 , The Research Group for Endoscopic Imaging of Korean Society of Gastrointestinal Endoscopy
Correspondence to: Sang Pyo Lee
ORCID https://orcid.org/0000-0002-4495-3714
E-mail ultra_pyo@hanmail.net
Jae Gon Lee and In Kyung Yoo contributed equally to this work as first authors.
*Current affiliation: Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Gut Liver 2024;18(3):444-456. https://doi.org/10.5009/gnl230244
Published online October 6, 2023, Published date May 15, 2024
Copyright © Gut and Liver.
Background/Aims: Recognizing Helicobacter pylori infection during endoscopy is important because it can lead to the performance of confirmatory testing. Linked color imaging (LCI) is an image enhancement technique that can improve the detection of gastrointestinal lesions. The purpose of this study was to compare LCI to conventional white light imaging (WLI) in the endoscopic diagnosis of H. pylori infection.
Methods: We conducted a comprehensive literature search using PubMed, Embase, and the Cochrane Library. All studies evaluating the diagnostic performance of LCI or WLI in the endoscopic diagnosis of H. pylori were eligible. Studies on magnifying endoscopy, chromoendoscopy, and artificial intelligence were excluded.
Results: Thirty-four studies were included in this meta-analysis, of which 32 reported the performance of WLI and eight reported the performance of LCI in diagnosing H. pylori infection. The pooled sensitivity and specificity of WLI in the diagnosis of H. pylori infection were 0.528 (95% confidence interval [CI], 0.517 to 0.540) and 0.821 (95% CI, 0.811 to 0.830), respectively. The pooled sensitivity and specificity of LCI in the diagnosis of H. pylori were 0.816 (95% CI, 0.790 to 0.841) and 0.868 (95% CI, 0.850 to 0.884), respectively. The pooled diagnostic odds ratios of WLI and LCI were 15.447 (95% CI, 8.225 to 29.013) and 31.838 (95% CI, 15.576 to 65.078), respectively. The areas under the summary receiver operating characteristic curves of WLI and LCI were 0.870 and 0.911, respectively.
Conclusions: LCI showed higher sensitivity in the endoscopic diagnosis of H. pylori infection than standard WLI.
Keywords: Helicobacter pylori, Gastrointestinal endoscopy, Image enhancement, Sensitivity and specificity
Helicobacter pylori causes chronic inflammatory reaction in the gastric mucosa, which leads to atrophy, intestinal metaplasia, and precancerous changes.1 Since H. pylori is a major risk factor for gastric cancer, it must be diagnosed and managed early for the presence or absence of infection.1,2
Various confirmatory tests are currently being used to investigate H. pylori infectivity, such as urea breath test, serologic test, rapid urease test, histology, culture, and stool antigen test.3 However, the prediction of H. pylori infection from endoscopic findings can play a decisive role in determining whether the confirmatory test should be conducted.4,5
Mucosal nodularity, rugal hypertrophy, mucosal edema, turbid gastric juice, diffuse redness, the absence of regular arrangement (RAC) of collecting venules, and hemorrhagic spots are typical endoscopic findings in the endoscopic diagnosis of H. pylori infection.4,6 However, since the accuracy of the endoscopic diagnosis of Helicobacter-associated gastritis using conventional white light imaging (WLI) is relatively low at 64% to 74%, there is a need for a better imaging technique.7-12
Linked color imaging (LCI) is an image-enhanced endoscopy method created by Fujifilm in 2013. This makes it easier to distinguish differences in mucosal color through expansion and reduction of color information.13-18 LCI enhances color contrast while maintaining the actual color of the target object, thereby making reds appear redder and whites appear whiter. Previous studies have shown that the sensitivity and accuracy of the endoscopic diagnosis of H. pylori infection using LCI were higher than those of conventional WLI.3,11,13-15,19,20
In this study, we tried to confirm the usefulness of LCI over WLI in the diagnosis of H. pylori infection based on previous studies. Therefore, we performed a systematic review and meta-analysis to determine the sensitivity and specificity of LCI as compared with WLI in the endoscopic diagnosis of H. pylori infection.
We conducted a systematic literature search in PubMed, Embase, and the Cochrane Library. In this process, we retrieved all human research articles published in English up to October 2022. We also hand-searched the reference lists of identified studies to ensure the relevance of all articles. The search string consisted of a combination of the following search terms: “Helicobacter pylori”, “H. pylori", “linked color*”, “LCI”, “white light*”, “endoscop*”, “gastroscop*”, “sensitivity”, “specificity.” The detailed search strategies used for each database are presented in the Supplementary Material. This study was admitted by the Institutional Review Board affiliated with Hallym University School of Medicine (HDT 2022-11-016).
All studies that evaluated the performances of WLI or LCI in the endoscopic diagnosis of H. pylori infection were considered eligible for inclusion. The exclusion criteria were as follows: (1) studies that only assessed magnifying endoscopy; (2) studies that only assessed chromoendoscopy; (3) studies that assessed the performance of artificial intelligence (AI); (4) studies that did not report sensitivity and specificity, or the absolute numbers of true positives, false positives, true negatives, and false negatives; (5) abstract-only publications; (6) non-original articles including review, editorial, opinion, letter, and case reports; and (7) non-English publications.
Two investigators (J.G.L. and I.K.Y.) independently screened and selected the literature. All duplicate articles that had been obtained from multiple databases were removed. And then, irrelevant articles were excluded based on the titles and abstracts. The full texts of the remaining articles were examined for eligibility. Any discrepancies between the two reviewers were resolved through discussion. A third party (S.P.L.) determined eligibility if such discrepancies could not be resolved. The study selection process was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses of Diagnostic Test Accuracy Studies Statement.21
We extracted data from the included studies by using a standardized collection sheet. If true negative, true positive, false negative, and false positive values were not presented in the study, they were calculated from total numbers, case numbers, sensitivity, and specificity. The study characteristics such as study design, study year, country, number of patients, prevalence of H. pylori infection, study population, method of reference standard testing, and criteria for endoscopic diagnosis were investigated.
The primary endpoint of this study was the pooled diagnostic performances of WLI and LCI in the endoscopic diagnosis of H. pylori infection. The pooled sensitivity, specificity, and diagnostic odds ratios of WLI and LCI, respectively, were evaluated.
To assess the quality of the included studies, we used the Quality Assessment of Diagnostic Accuracy Studies‐2 tool.22 It assesses the risk of bias of diagnostic studies in the following four domains: index test, patient selection, flow and timing, and reference standard. Each domain is assessed for the risk of bias with signaling questions, and the first three domains are assessed for concerns regarding applicability.
True negative, true positive, false negative, and false positive were calculated for all included studies. Meta-DiSc 1.4 software was used to perform a meta-analysis.23 The DerSimonian-Laird random effects method was used for data integration. The diagnostic performances of LCI and WLI in the endoscopic diagnosis of H. pylori infection were determined by estimating the pooled sensitivity, specificity, and diagnostic odds ratios with 95% confidence intervals (CIs). To compare the sensitivity and specificity of WLI and LCI, we analyzed data from studies in which both imaging modalities were conducted in the same population, and the McNemar test was used for statistical comparison. Forest plot and summary receiver operator characteristic curves were also constructed. We performed a two-sample Z-test to compare the differences in the area under the curve (AUC) of the two tests (WLI and LCI) based on Q* values and their standard errors. Heterogeneity between studies was evaluated using Higgins I2 statistics. To assess the effects of possible sources of heterogeneity, meta-regression and subgroup analyses were performed while including the following covariates: study year, study location, number of patients, study population, prevalence of H. pylori infection, reference standard, and index test.
In total, 2,063 potentially relevant articles were extracted from databases through a systematic literature search and confirmed by manual searching. First, 730 duplicate articles were removed from the initial extracted articles. Next, 1,258 articles were excluded by titles and abstracts. Subsequently, we reviewed the full text of 75 articles for eligibility. Forty-one articles were excluded because they had irrelevant intervention or outcomes (n=15), were review articles (n=2), were conference abstracts without a full text (n=22), or had insufficient detailed data (n=2). As a result, 34 articles were ultimately included in the meta-analysis.10,11,13,14,20,24-52 Fig. 1 shows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses flowchart of this process.
Table 1 lists the characteristics of the 34 studies included in the meta-analysis. Out of these, 32 evaluated the diagnostic performance of WLI and eight evaluated LCI, and six evaluated both WLI and LCI. Of the 32 studies evaluating WLI, 17 studies were conducted in Asia and 15 studies were conducted in non-Asia regions; eight studies investigated endoscopic evaluations in children. All studies evaluating LCI were conducted in Asia. Almost all studies used tissue-based confirmatory testing as a reference standard for H. pylori infection. Rapid urease test and histological assessment were the most common methods for confirmatory testing. Only three studies used noninvasive testing as reference standard, including urea breath test, serological testing, or stool antigen testing. Of the 34 studies, 16 used comprehensive diagnostic criteria for the endoscopic diagnosis of H. pylori infection whereas the other 18 used single endoscopic findings.
Table 1. Characteristics of the Included Studies
Study | Country | No. of patients | Prevalence of HP infection | Population | Reference standard | Index test |
---|---|---|---|---|---|---|
Studies evaluating WLI (n=32) | ||||||
Adu-Aryee et al. (2016)24 | Ghana | 76 | 51.3 | Adult | RUT | Comprehensive |
Bah et al. (1995)25 | Switzerland | 86 | 46.5 | Adult | RUT, histology | Comprehensive |
Cho et al. (2013)26 | Korea | 617 | 58.2 | Adult | RUT, histology | Comprehensive |
Cho et al. (2021)27 | Korea | 254 | 64.2 | Adult | RUT, molecular test | Comprehensive |
Dohi et al. (2016)11 | Japan | 60 | 50.0 | Adult | RUT, histology, serology, UBT | Single finding(s) |
Emami et al. (2007)28 | Iran | 501 | 65.1 | Adult | RUT, histology | Single finding(s) |
Fiuza et al. (2021)29 | Brazil | 187 | 25.1 | Adult | RUT, histology | Single finding(s) |
Garcés-Durán et al. (2019)30 | Spain | 140 | 31.4 | Adult | RUT, histology | Single finding(s) |
Gonen et al. (2009)31 | Turkey | 129 | 76.0 | Adult | RUT, histology, UBT | Single finding(s) |
Hidaka et al. (2010)32 | Japan | 87 | 28.7 | Children | Histology, serology, UBT | Single finding(s) |
Katake et al. (2013)33 | Japan | 723 | 70.5 | Adult | Histology, serology | Single finding(s) |
Laine et al. (1995)34 | US | 52 | 53.8 | Adult | Histology | Single finding(s) |
Łazowska-Przeorek et al. (2015)35 | Poland | 341 | 31.4 | Children | RUT, histology, stool antigen, UBT | Single finding(s) |
Lee et al. (2020)20 | Korea | 100 | 37.0 | Adult | RUT, histology | Comprehensive |
Luzza et al. (2001)36 | Italy | 174 | 48.3 | Children | RUT, histology | Single finding(s) |
Machado et al. (2008)37 | Brazil | 99 | 32.3 | Children | RUT, histology | Single finding(s) |
Matrakool et al. (2016)38 | Thailand | 200 | 66.0 | Adult | RUT, histology | Comprehensive |
Mazigh Mrad et al. (2012)39 | Tunisia | 49 | 71.4 | Children | RUT, histology | Single finding(s) |
Niyasom et al. (2019)40 | Thailand | 48 | 25.0 | Children | RUT, histology | Single finding(s) |
Ono et al. (2020)41 | Japan | 127 | 50.4 | Adult | UBT, serology | Single finding(s) |
Rafeey et al. (2004)42 | Iran | 124 | 46.0 | Children | RUT, histology | Single finding(s) |
Redéen et al. (2003)10 | Sweden | 488 | 40.4 | Adult | RUT, histology | Comprehensive |
Sun et al. (2019)43 | China | 253 | 42.3 | Adult | RUT, histology | Comprehensive |
Tahara et al. (2019)44 | Japan | 163 | 46.9 | Adult | Histology, serology, UBT | Comprehensive |
Tomić et al. (2009)45 | Bosnia | 195 | 20.5 | Children | Histology | Single finding(s) |
Toyoshima et al. (2020)46 | Japan | 265 | 15.8 | Adult | RUT, histology | Single finding(s) |
Wang et al. (2019)47 | China | 103 | 26.2 | Adult | RUT, histology | Comprehensive |
Xiu et al. (2021)48 | China | 392 | 34.4 | Adult | RUT, histology, UBT | Comprehensive |
Yagi et al. (2014)49 | Japan | 56 | 58.9 | Adult | Stool antigen | Comprehensive |
Yan et al. (2010)50 | Taiwan | 112 | 67.9 | Adult | RUT, histology | Comprehensive |
Yela et al. (1997)51 | Spain | 150 | 76.7 | Adult | RUT, histology, tissue culture | Comprehensive |
Zhao et al. (2020)52 | China | 583 | 42.2 | Adult | RUT, UBT | Comprehensive |
Studies evaluating LCI (n=8) | ||||||
Chen et al. (2018)13 | Taiwan | 111 | 27.9 | Adult | RUT, histology, UBT | Single finding(s) |
Dohi et al. (2016)11 | Japan | 60 | 50.0 | Adult | RUT, histology, serology, UBT | Single finding(s) |
Jiang et al. (2019)14 | China | 358 | 35.5 | Adult | RUT, histology, UBT | Comprehensive |
Lee et al. (2020)20 | Korea | 100 | 37.0 | Adult | RUT, histology | Comprehensive |
Ono et al. (2020)41 | Japan | 127 | 50.4 | Adult | UBT, serology | Single finding(s) |
Sun et al. (2019)43 | China | 253 | 42.3 | Adult | RUT, histology | Comprehensive |
Wang et al. (2019)47 | China | 103 | 26.2 | Adult | RUT, histology | Comprehensive |
Xiu et al. (2021)48 | China | 392 | 34.4 | Adult | RUT, histology, UBT | Comprehensive |
HP, Helicobacter pylori; WLI, white light imaging; LCI, linked color imaging; RUT, rapid urease test; UBT, urea breath test.
The Quality Assessment of Diagnostic Accuracy Studies‐2 criteria were used to assess the quality of the included studies. Thirteen studies were ranked as having a high or unclear risk of bias in patient selection. All studies were rated as having a low risk of bias in the reference standard and the flow and timing domains. The overall quality assessment is presented in Supplementary Table 1.
Figs 2 and 3 show pooled estimates of the sensitivity and specificity of WLI and LCI in the endoscopic diagnosis of H. pylori infection. The pooled sensitivity values of WLI and LCI for diagnosing H. pylori infection were 0.528 (95% CI, 0.517 to 0.540) and 0.816 (95% CI, 0.790 to 0.841), respectively. The pooled specificity values of WLI and LCI were 0.821 (95% CI, 0.811 to 0.830) and 0.868 (95% CI, 0.850 to 0.884), respectively. The pooled diagnostic odds ratios of WLI and LCI were 15.447 (95% CI, 8.225 to 29.013) and 31.838 (95% CI, 15.576 to 65.078), respectively. The summary receiver operator characteristic curves showed that the derived AUC of WLI and LCI for diagnosing H. pylori infection were 0.870 and 0.911, respectively, and the difference was statistically significant (p<0.001) (Fig. 4).
To directly compare the sensitivity and specificity of WLI and LCI, we used paired data from six studies that both WLI and LCI were conducted on the same patients.11,20,41,43,48,53 The pooled sensitivity of LCI was significantly higher than that of WLI (0.818 [95% CI, 0.790 to 0.845] vs 0.651 [95% CI, 0.618 to 0.685], p<0.001). The pooled specificity was also significantly higher for LCI compared to WLI (0.848 [95% CI, 0.828 to 0.867] vs 0.785 [95% CI, 0.762 to 0.807], p<0.001) (Fig. 5).
Table 2 lists the results of the univariate meta-regression analysis for determining potential factors of heterogeneity. In studies evaluating WLI, the location of the study was analyzed as a probable source of heterogeneity. The study year was divided into before and after/during 2002, which is the year that high-definition endoscopy began to be used, which did not result in significant heterogeneity. For index tests, endoscopic diagnosis was divided into diagnoses based on single findings or on comprehensive criteria, and this did not result in significant heterogeneity. In studies evaluating LCI, all studies were conducted in Asia and in 2016 or later. We could not identify any factors that were a possible source of heterogeneity.
Table 2. Univariate Meta-Regression Analysis for Identifying Potential Factors of Heterogeneity
Variable | Coefficient | p-value |
---|---|---|
Studies evaluating WLI (n=32) | ||
Study year (after or during 2002 vs before 2002) | –1.039 | 0.359 |
Study location (Asia vs non-Asia) | 1.449 | 0.043 |
No. of patients (≥145 vs <145) | 1.155 | 0.111 |
Study population (adult vs children) | –1.088 | 0.217 |
Prevalence of HP infection (≥46.7% vs <46.7%) | 0.197 | 0.791 |
Reference standard (single testing vs multiple testing) | 0.955 | 0.388 |
Endoscopic diagnosis (based on single finding(s) vs comprehensive diagnosis) | 0.711 | 0.355 |
Studies evaluating LCI (n=8) | ||
No. of patients (≥119 vs <119) | 1.585 | 0.088 |
Prevalence of HP infection (≥36.25% vs <36.25%) | 0.295 | 0.797 |
Endoscopic diagnosis (based on single finding(s) vs comprehensive diagnosis) | –0.086 | 0.944 |
WLI, white light imaging; HP, Helicobacter pylori; LCI, linked color imaging.
Table 3 presents the results of the subgroup analysis. Comparing the diagnostic performance of WLI according to study location, the pooled sensitivity values were 0.828 (95% CI, 0.814 to 0.841) in 17 Asian studies and 0.311 (95% CI, 0.297 to 0.325) in 15 non-Asian studies. Meanwhile, the pooled specificity values were 0.845 (95% CI, 0.833 to 0.857) and 0.795 (95% CI, 0.781 to 0.809) in Asian and non-Asian studies, respectively.
Table 3. Subgroup Analysis for the Diagnostic Performance of WLI and LCI
Variable | No. of studies | Sensitivity (95% CI) | Specificity (95% CI) | Diagnostic OR (95% CI) |
---|---|---|---|---|
Studies evaluating WLI (n=32) | ||||
Study year | ||||
After or during 2002 | 28 | 0.527 (0.515–0.538) | 0.823 (0.814–0.833) | 17.569 (8.922–34.596) |
Before 2002 | 4 | 0.568 (0.510–0.624) | 0.753 (0.696–0.804) | 5.929 (1.024–34.342) |
Study location | ||||
Asia | 17 | 0.828 (0.814–0.841) | 0.845 (0.833–0.857) | 29.355 (13.734–62.744) |
Non-Asia | 15 | 0.311 (0.297–0.325) | 0.795 (0.781–0.809) | 6.724 (3.263–13.858) |
No. of patients | ||||
≥145 | 16 | 0.515 (0.503–0.528) | 0.834 (0.824–0.844) | 27.207 (10.439–70.910) |
<145 | 16 | 0.578 (0.553–0.603) | 0.772 (0.750–0.793) | 7.957 (3.794–16.686) |
Study population | ||||
Adult | 24 | 0.514 (0.503–0.526) | 0.810 (0.799–0.820) | 12.069 (6.105–23.859) |
Children | 8 | 0.729 (0.687–0.768) | 0.892 (0.869–0.911) | 35.657 (5.708–222.75) |
Prevalence of HP infection | ||||
≥46.7% | 16 | 0.491 (0.478–0.504) | 0.840 (0.827–0.853) | 17.748 (6.198–50.825) |
<46.7% | 16 | 0.646 (0.624–0.669) | 0.803 (0.789–0.816) | 13.598 (6.102–30.301) |
Reference standard | ||||
Single testing | 4 | 0.597 (0.520–0.661) | 0.819 (0.769–0.862) | 6.884 (1.264–37.475) |
Multiple testing | 28 | 0.527 (0.515–0.538) | 0.821 (0.811–0.830) | 17.432 (8.821–34.449) |
Endoscopic diagnosis | ||||
Based on single finding(s) | 17 | 0.435 (0.422–0.449) | 0.867 (0.856–0.878) | 21.703 (7.255–64.924) |
Comprehensive diagnosis | 15 | 0.732 (0.714–0.750) | 0.757 (0.741–0.773) | 10.812 (5.019–23.295) |
Studies evaluating LCI (n=8) | ||||
No. of patients | ||||
≥119 | 4 | 0.870 (0.839–0.897) | 0.893 (0.871–0.912) | 67.727 (29.385–156.10) |
<119 | 4 | 0.731 (0.681–0.776) | 0.828 (0.795–0.857) | 14.976 (6.904–32.487) |
Prevalence | ||||
≥36.25% | 4 | 0.793 (0.752–0.830) | 0.864 (0.833–0.891) | 33.296 (15.983–69.363) |
<36.25% | 4 | 0.838 (0.802–0.870) | 0.870 (0.847–0.890) | 34.508 (7.975–149.31) |
Endoscopic diagnosis | ||||
Based on single finding(s) | 3 | 0.874 (0.823–0.916) | 0.817 (0.765–0.862) | 28.734 (10.766–76.692) |
Comprehensive diagnosis | 5 | 0.799 (0.767–0.828) | 0.878 (0.859–0.895) | 35.563 (12.868–98.284) |
WLI, white light imaging; LCI, linked color imaging; OR, odds ratio; CI, confidence interval; HP, Helicobacter pylori.
Our meta-analysis showed that LCI was more sensitive than WLI in the endoscopic diagnosis of H. pylori infection, with a pooled sensitivity of 0.816 compared to 0.528 for WLI. Redness of the fundus gland mucosa, mucosal edema, mucosal nodularity, mucus lake turbidity, rugal hypertrophy, loss of RAC of collecting venules, and hemorrhagic spots are all markers for diagnosing H. pylori gastritis.6 Since LCI enhances color contrast, it facilitates the identification of these typical endoscopic findings.14,15,54 Moreover, under LCI, H. pylori-infected mucosa appeared deep red (crimson) in color, while H. pylori-negative mucosa (past infection or uninfected patients) could clearly be observed as apricot in color, which could be detected better because of distinctive color differences.11,13,41 Dohi et al.11 showed that LCI improved the endoscopic diagnosis of active H. pylori infections, with 10% to 15% improvements in accuracy, sensitivity, and specificity over WLI. In a multicenter prospective study reported by Ono et al.41 comparing the accuracy of LCI and WLI for the endoscopic diagnosis of H. pylori gastritis, LCI was found to be significantly more accurate than WLI in patients with past infections. Our meta-analysis also demonstrated that the LCI patterns are more sensitive than the WLI patterns in diagnosing H. pylori infection, suggesting that LCI can compensate for the low sensitivity of WLI.
When typical endoscopic findings such as mucosal nodularity or mucosal swelling appear, the accuracy of endoscopic diagnosis of H. pylori infection is very high, even under WLI.8 However, in the absence of these typical findings, considerable knowledge and experience may be needed to accurately determine the presence or absence of infection. Our subgroup analysis also identified that the sensitivity of diagnosis was higher in Asian countries than in non-Asian countries. These suggest that high incidence of H. pylori infection and rich experience in endoscopic diagnosis may play an important role in endoscopic diagnosis of H. pylori infection. However, when analyzing the results of six Asian studies that assessed the performance of both WLI and LCI in endoscopic diagnosis of H. pylori infection in the same population, LCI was superior to WLI in both sensitivity and specificity (sensitivity, 0.818 vs 0.651; specificity, 0.848 vs 0.785). In mass screening for gastric cancer and precursor H. pylori gastritis, screening endoscopy with high sensitivity and specificity for endoscopic diagnosis of H. pylori infection might have a significant impact on reducing gastric cancer-related morbidity and mortality. Image-enhanced endoscopy with LCI is expected to play an important role in screening for H. pylori gastritis.
Image-enhanced endoscopy presents images through filtering of illuminating light and/or computing captured electrical images. Narrow-band imaging (NBI; Olympus, Tokyo, Japan) is the most widely used and studied method for the detection of gastrointestinal lesions. Several retrospective studies have shown that NBI is useful in diagnosing H. pylori infection. Alaboudy et al.55 retrospectively assessed H. pylori-infected gastric mucosa, and they classified mucosal patterns into five categories. The classification was found to be well-correlated with histopathological grades of H. pylori gastritis. Tongtawee et al.56 assessed the NBI-based classification system developed by Alaboudy et al.55 and found that types 3, 4, and 5 all had both sensitivity and specificity over 90% for predicting H. pylori positivity. However, a prospective multicenter study for the real-time use of NBI in the diagnosis of gastric lesions including H. pylori gastritis found that the diagnostic accuracy on H. pylori gastritis of WLI and NBI was similar.57 Data are scarce on the diagnostic accuracy of i-scan, another digital image enhancement technique (Pentax Medical, Tokyo, Japan), in diagnosing H. pylori infection. One pilot study has investigated the diagnostic accuracy of i-scan, which showed better diagnostic accuracy of i-scan over conventional WLI in diagnosing H. pylori infection.58
The utility of LCI compared to other image-enhanced techniques is that it can be easily applied in screening endoscopy. NBI is useful in the characterization of known localized lesions, but it may not be appropriate for screening endoscopy, because the light intensity is insufficient to inspect the stomach from a distant view. By contrast, images produced by LCI are brighter and the color contrast is clearer than WLI.59 LCI can observe the entire gastric mucosa with bright images, so it is considered to be a useful tool for diagnosing diffuse gastric lesions such as H. pylori-associated gastritis. Therefore, LCI could be a good screening tool for the real-time diagnosis of H. pylori infection. The routine use of LCI in screening endoscopy would provide valuable information on H. pylori infection status that cannot be obtained using conventional WLI alone.
Magnifying NBI may also be helpful for the endoscopic diagnosis of H. pylori infection. Yagi et al.60 reported that magnifying NBI can detect the RAC of collecting venules in H. pylori-negative normal stomachs. Abnormal mucosal patterns without RAC which were classified as Z-1 to Z-3 were considered as characteristics of H. pylori-infected stomach in magnifying NBI.61 However, magnifying NBI may not be widely used in clinical practice because it takes more time for inspection and has a long learning curve.31
AI will be the trend of future diagnostic technology. However, since our meta-analysis aimed to compare the performance of WLI and LCI, our study intentionally excluded AI-related studies from the analysis. There have already been several systematic reviews and meta-analyses related to AI for endoscopic diagnosis of H. pylori infection recently. In a meta-analysis published in 2020, the performance of AI was superior to endoscopists in the prediction of H. pylori infection (AUC, 0.90 vs 0.82; p<0.001).62 In another meta-analysis published in the same year, pooled sensitivity, specificity, and AUC of AI for the diagnosis of H. pylori infection were 0.87 (95% CI, 0.72 to 0.94), 0.86 (95% CI, 0.77 to 0.92), and 0.92 (95% CI, 0.90 to 0.94).63 A new meta-analysis was published in 2022, and the pooled accuracy was 79.6% (95% CI, 66.7 to 90.0) with a significant heterogeneity (I2=97.9%; 95% CI, 97.2 to 98.6).64 AI-related studies for the diagnosis of H. pylori infection are expected to continue in the future, and good results are expected.
The limitations of this study are as follows. First, significant heterogeneity was found in the pooled estimates of each diagnostic testing. Heterogeneity is a common issue reported in systematic reviews of studies on diagnostic test accuracy.65 Although we identified possible sources of heterogeneity through meta-regression analysis, this heterogeneity was not resolved in the subgroup analysis. The criteria for the endoscopic diagnosis of H. pylori infection in the included studies were all different, which may have contributed substantially to the heterogeneity of the pooled estimates. Second, publication bias was not assessed. Because there are no reliable methods for assessing publication bias in diagnostic test accuracy studies,66 this issue is considered insurmountable. Third, in the quality assessment of the included studies, more than one-third of studies (13 of 34 studies) rated a high or unclear risk of bias in the patient selection domain. This was because these studies were retrospective and did not specify whether or not to enroll patients consecutively. Fourth, since various endoscopic characteristics must be comprehensively judged for endoscopic diagnosis, inter-observer bias exists in these studies. Although there have been many individual studies, the endoscopic features of current H. pylori infection using LCI are not yet well standardized. Recently, to compensate for these limitations, a computer-aided diagnostic system for diagnosing H. pylori infection status using LCI has been developed, and it has shown good results.62-64,67-69 AI technology with IEE is likely to become a useful image diagnostic tool in the future. In order to better utilize the AI-based LCI, we should focus on the color variations of gastric mucosa and create sophisticated diagnostic algorithms in machine-learning system. Finally, all studies evaluating LCI were conducted in Asia. In the future, non-Asian studies on LCI need to be conducted for better meta-analysis.
In summary, this is the first meta-analysis study to evaluate the overall diagnostic ability of conventional WLI and LCI in the endoscopic diagnosis of H. pylori infection. This study revealed that LCI could be useful as a diagnostic tool for H. pylori infection. LCI can provide additional diagnostic ability to conventional endoscopy for H. pylori gastritis, and it could be an effective and convenient tool for detecting and monitoring H. pylori infection in clinical practice. We believe that prospective large-scale studies, especially in non-Asian countries, are needed to validate the effectiveness of LCI in diagnosing H. pylori gastritis. Further using a combination of image-enhanced endoscopy technology with AI could improve the diagnostic accuracy in the future.
This research was supported by Korean Gastrointestinal Endoscopy Research Foundation, 2022 (6H220301001S000100).
No potential conflict of interest relevant to this article was reported.
Study concept and design: S.P.L. Data acquisition: J.G.L., I.K.Y. Data analysis and interpretation: S.P.L., J.G.L., I.K.Y. Drafting of the manuscript: S.P.L., J.G.L., I.K.Y. Critical revision of the manuscript for important intellectual content: A.O.Y. Statistical analysis: J.G.L. Obtained funding: S.P.L. Administrative, technical, or material support; study supervision: S.P.L. Approval of final manuscript: all authors.
Supplementary materials can be accessed at https://doi.org/10.5009/gnl230244.
Gut and Liver 2024; 18(3): 444-456
Published online May 15, 2024 https://doi.org/10.5009/gnl230244
Copyright © Gut and Liver.
Jae Gon Lee1 , In Kyung Yoo2 , Abdullah Ozgur Yeniova3 , Sang Pyo Lee1 , The Research Group for Endoscopic Imaging of Korean Society of Gastrointestinal Endoscopy
1Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea; 2Department of Gastroenterology, CHA Bundang Medical Center, CHA University College of Medicine, Seongnam, Korea; 3Division of Gastroenterology, Department of Internal Medicine, Tokat Gaziosmanpasa University School of Medicine, Tokat, Turkey
Correspondence to:Sang Pyo Lee
ORCID https://orcid.org/0000-0002-4495-3714
E-mail ultra_pyo@hanmail.net
Jae Gon Lee and In Kyung Yoo contributed equally to this work as first authors.
*Current affiliation: Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background/Aims: Recognizing Helicobacter pylori infection during endoscopy is important because it can lead to the performance of confirmatory testing. Linked color imaging (LCI) is an image enhancement technique that can improve the detection of gastrointestinal lesions. The purpose of this study was to compare LCI to conventional white light imaging (WLI) in the endoscopic diagnosis of H. pylori infection.
Methods: We conducted a comprehensive literature search using PubMed, Embase, and the Cochrane Library. All studies evaluating the diagnostic performance of LCI or WLI in the endoscopic diagnosis of H. pylori were eligible. Studies on magnifying endoscopy, chromoendoscopy, and artificial intelligence were excluded.
Results: Thirty-four studies were included in this meta-analysis, of which 32 reported the performance of WLI and eight reported the performance of LCI in diagnosing H. pylori infection. The pooled sensitivity and specificity of WLI in the diagnosis of H. pylori infection were 0.528 (95% confidence interval [CI], 0.517 to 0.540) and 0.821 (95% CI, 0.811 to 0.830), respectively. The pooled sensitivity and specificity of LCI in the diagnosis of H. pylori were 0.816 (95% CI, 0.790 to 0.841) and 0.868 (95% CI, 0.850 to 0.884), respectively. The pooled diagnostic odds ratios of WLI and LCI were 15.447 (95% CI, 8.225 to 29.013) and 31.838 (95% CI, 15.576 to 65.078), respectively. The areas under the summary receiver operating characteristic curves of WLI and LCI were 0.870 and 0.911, respectively.
Conclusions: LCI showed higher sensitivity in the endoscopic diagnosis of H. pylori infection than standard WLI.
Keywords: Helicobacter pylori, Gastrointestinal endoscopy, Image enhancement, Sensitivity and specificity
Helicobacter pylori causes chronic inflammatory reaction in the gastric mucosa, which leads to atrophy, intestinal metaplasia, and precancerous changes.1 Since H. pylori is a major risk factor for gastric cancer, it must be diagnosed and managed early for the presence or absence of infection.1,2
Various confirmatory tests are currently being used to investigate H. pylori infectivity, such as urea breath test, serologic test, rapid urease test, histology, culture, and stool antigen test.3 However, the prediction of H. pylori infection from endoscopic findings can play a decisive role in determining whether the confirmatory test should be conducted.4,5
Mucosal nodularity, rugal hypertrophy, mucosal edema, turbid gastric juice, diffuse redness, the absence of regular arrangement (RAC) of collecting venules, and hemorrhagic spots are typical endoscopic findings in the endoscopic diagnosis of H. pylori infection.4,6 However, since the accuracy of the endoscopic diagnosis of Helicobacter-associated gastritis using conventional white light imaging (WLI) is relatively low at 64% to 74%, there is a need for a better imaging technique.7-12
Linked color imaging (LCI) is an image-enhanced endoscopy method created by Fujifilm in 2013. This makes it easier to distinguish differences in mucosal color through expansion and reduction of color information.13-18 LCI enhances color contrast while maintaining the actual color of the target object, thereby making reds appear redder and whites appear whiter. Previous studies have shown that the sensitivity and accuracy of the endoscopic diagnosis of H. pylori infection using LCI were higher than those of conventional WLI.3,11,13-15,19,20
In this study, we tried to confirm the usefulness of LCI over WLI in the diagnosis of H. pylori infection based on previous studies. Therefore, we performed a systematic review and meta-analysis to determine the sensitivity and specificity of LCI as compared with WLI in the endoscopic diagnosis of H. pylori infection.
We conducted a systematic literature search in PubMed, Embase, and the Cochrane Library. In this process, we retrieved all human research articles published in English up to October 2022. We also hand-searched the reference lists of identified studies to ensure the relevance of all articles. The search string consisted of a combination of the following search terms: “Helicobacter pylori”, “H. pylori", “linked color*”, “LCI”, “white light*”, “endoscop*”, “gastroscop*”, “sensitivity”, “specificity.” The detailed search strategies used for each database are presented in the Supplementary Material. This study was admitted by the Institutional Review Board affiliated with Hallym University School of Medicine (HDT 2022-11-016).
All studies that evaluated the performances of WLI or LCI in the endoscopic diagnosis of H. pylori infection were considered eligible for inclusion. The exclusion criteria were as follows: (1) studies that only assessed magnifying endoscopy; (2) studies that only assessed chromoendoscopy; (3) studies that assessed the performance of artificial intelligence (AI); (4) studies that did not report sensitivity and specificity, or the absolute numbers of true positives, false positives, true negatives, and false negatives; (5) abstract-only publications; (6) non-original articles including review, editorial, opinion, letter, and case reports; and (7) non-English publications.
Two investigators (J.G.L. and I.K.Y.) independently screened and selected the literature. All duplicate articles that had been obtained from multiple databases were removed. And then, irrelevant articles were excluded based on the titles and abstracts. The full texts of the remaining articles were examined for eligibility. Any discrepancies between the two reviewers were resolved through discussion. A third party (S.P.L.) determined eligibility if such discrepancies could not be resolved. The study selection process was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses of Diagnostic Test Accuracy Studies Statement.21
We extracted data from the included studies by using a standardized collection sheet. If true negative, true positive, false negative, and false positive values were not presented in the study, they were calculated from total numbers, case numbers, sensitivity, and specificity. The study characteristics such as study design, study year, country, number of patients, prevalence of H. pylori infection, study population, method of reference standard testing, and criteria for endoscopic diagnosis were investigated.
The primary endpoint of this study was the pooled diagnostic performances of WLI and LCI in the endoscopic diagnosis of H. pylori infection. The pooled sensitivity, specificity, and diagnostic odds ratios of WLI and LCI, respectively, were evaluated.
To assess the quality of the included studies, we used the Quality Assessment of Diagnostic Accuracy Studies‐2 tool.22 It assesses the risk of bias of diagnostic studies in the following four domains: index test, patient selection, flow and timing, and reference standard. Each domain is assessed for the risk of bias with signaling questions, and the first three domains are assessed for concerns regarding applicability.
True negative, true positive, false negative, and false positive were calculated for all included studies. Meta-DiSc 1.4 software was used to perform a meta-analysis.23 The DerSimonian-Laird random effects method was used for data integration. The diagnostic performances of LCI and WLI in the endoscopic diagnosis of H. pylori infection were determined by estimating the pooled sensitivity, specificity, and diagnostic odds ratios with 95% confidence intervals (CIs). To compare the sensitivity and specificity of WLI and LCI, we analyzed data from studies in which both imaging modalities were conducted in the same population, and the McNemar test was used for statistical comparison. Forest plot and summary receiver operator characteristic curves were also constructed. We performed a two-sample Z-test to compare the differences in the area under the curve (AUC) of the two tests (WLI and LCI) based on Q* values and their standard errors. Heterogeneity between studies was evaluated using Higgins I2 statistics. To assess the effects of possible sources of heterogeneity, meta-regression and subgroup analyses were performed while including the following covariates: study year, study location, number of patients, study population, prevalence of H. pylori infection, reference standard, and index test.
In total, 2,063 potentially relevant articles were extracted from databases through a systematic literature search and confirmed by manual searching. First, 730 duplicate articles were removed from the initial extracted articles. Next, 1,258 articles were excluded by titles and abstracts. Subsequently, we reviewed the full text of 75 articles for eligibility. Forty-one articles were excluded because they had irrelevant intervention or outcomes (n=15), were review articles (n=2), were conference abstracts without a full text (n=22), or had insufficient detailed data (n=2). As a result, 34 articles were ultimately included in the meta-analysis.10,11,13,14,20,24-52 Fig. 1 shows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses flowchart of this process.
Table 1 lists the characteristics of the 34 studies included in the meta-analysis. Out of these, 32 evaluated the diagnostic performance of WLI and eight evaluated LCI, and six evaluated both WLI and LCI. Of the 32 studies evaluating WLI, 17 studies were conducted in Asia and 15 studies were conducted in non-Asia regions; eight studies investigated endoscopic evaluations in children. All studies evaluating LCI were conducted in Asia. Almost all studies used tissue-based confirmatory testing as a reference standard for H. pylori infection. Rapid urease test and histological assessment were the most common methods for confirmatory testing. Only three studies used noninvasive testing as reference standard, including urea breath test, serological testing, or stool antigen testing. Of the 34 studies, 16 used comprehensive diagnostic criteria for the endoscopic diagnosis of H. pylori infection whereas the other 18 used single endoscopic findings.
Table 1 . Characteristics of the Included Studies.
Study | Country | No. of patients | Prevalence of HP infection | Population | Reference standard | Index test |
---|---|---|---|---|---|---|
Studies evaluating WLI (n=32) | ||||||
Adu-Aryee et al. (2016)24 | Ghana | 76 | 51.3 | Adult | RUT | Comprehensive |
Bah et al. (1995)25 | Switzerland | 86 | 46.5 | Adult | RUT, histology | Comprehensive |
Cho et al. (2013)26 | Korea | 617 | 58.2 | Adult | RUT, histology | Comprehensive |
Cho et al. (2021)27 | Korea | 254 | 64.2 | Adult | RUT, molecular test | Comprehensive |
Dohi et al. (2016)11 | Japan | 60 | 50.0 | Adult | RUT, histology, serology, UBT | Single finding(s) |
Emami et al. (2007)28 | Iran | 501 | 65.1 | Adult | RUT, histology | Single finding(s) |
Fiuza et al. (2021)29 | Brazil | 187 | 25.1 | Adult | RUT, histology | Single finding(s) |
Garcés-Durán et al. (2019)30 | Spain | 140 | 31.4 | Adult | RUT, histology | Single finding(s) |
Gonen et al. (2009)31 | Turkey | 129 | 76.0 | Adult | RUT, histology, UBT | Single finding(s) |
Hidaka et al. (2010)32 | Japan | 87 | 28.7 | Children | Histology, serology, UBT | Single finding(s) |
Katake et al. (2013)33 | Japan | 723 | 70.5 | Adult | Histology, serology | Single finding(s) |
Laine et al. (1995)34 | US | 52 | 53.8 | Adult | Histology | Single finding(s) |
Łazowska-Przeorek et al. (2015)35 | Poland | 341 | 31.4 | Children | RUT, histology, stool antigen, UBT | Single finding(s) |
Lee et al. (2020)20 | Korea | 100 | 37.0 | Adult | RUT, histology | Comprehensive |
Luzza et al. (2001)36 | Italy | 174 | 48.3 | Children | RUT, histology | Single finding(s) |
Machado et al. (2008)37 | Brazil | 99 | 32.3 | Children | RUT, histology | Single finding(s) |
Matrakool et al. (2016)38 | Thailand | 200 | 66.0 | Adult | RUT, histology | Comprehensive |
Mazigh Mrad et al. (2012)39 | Tunisia | 49 | 71.4 | Children | RUT, histology | Single finding(s) |
Niyasom et al. (2019)40 | Thailand | 48 | 25.0 | Children | RUT, histology | Single finding(s) |
Ono et al. (2020)41 | Japan | 127 | 50.4 | Adult | UBT, serology | Single finding(s) |
Rafeey et al. (2004)42 | Iran | 124 | 46.0 | Children | RUT, histology | Single finding(s) |
Redéen et al. (2003)10 | Sweden | 488 | 40.4 | Adult | RUT, histology | Comprehensive |
Sun et al. (2019)43 | China | 253 | 42.3 | Adult | RUT, histology | Comprehensive |
Tahara et al. (2019)44 | Japan | 163 | 46.9 | Adult | Histology, serology, UBT | Comprehensive |
Tomić et al. (2009)45 | Bosnia | 195 | 20.5 | Children | Histology | Single finding(s) |
Toyoshima et al. (2020)46 | Japan | 265 | 15.8 | Adult | RUT, histology | Single finding(s) |
Wang et al. (2019)47 | China | 103 | 26.2 | Adult | RUT, histology | Comprehensive |
Xiu et al. (2021)48 | China | 392 | 34.4 | Adult | RUT, histology, UBT | Comprehensive |
Yagi et al. (2014)49 | Japan | 56 | 58.9 | Adult | Stool antigen | Comprehensive |
Yan et al. (2010)50 | Taiwan | 112 | 67.9 | Adult | RUT, histology | Comprehensive |
Yela et al. (1997)51 | Spain | 150 | 76.7 | Adult | RUT, histology, tissue culture | Comprehensive |
Zhao et al. (2020)52 | China | 583 | 42.2 | Adult | RUT, UBT | Comprehensive |
Studies evaluating LCI (n=8) | ||||||
Chen et al. (2018)13 | Taiwan | 111 | 27.9 | Adult | RUT, histology, UBT | Single finding(s) |
Dohi et al. (2016)11 | Japan | 60 | 50.0 | Adult | RUT, histology, serology, UBT | Single finding(s) |
Jiang et al. (2019)14 | China | 358 | 35.5 | Adult | RUT, histology, UBT | Comprehensive |
Lee et al. (2020)20 | Korea | 100 | 37.0 | Adult | RUT, histology | Comprehensive |
Ono et al. (2020)41 | Japan | 127 | 50.4 | Adult | UBT, serology | Single finding(s) |
Sun et al. (2019)43 | China | 253 | 42.3 | Adult | RUT, histology | Comprehensive |
Wang et al. (2019)47 | China | 103 | 26.2 | Adult | RUT, histology | Comprehensive |
Xiu et al. (2021)48 | China | 392 | 34.4 | Adult | RUT, histology, UBT | Comprehensive |
HP, Helicobacter pylori; WLI, white light imaging; LCI, linked color imaging; RUT, rapid urease test; UBT, urea breath test..
The Quality Assessment of Diagnostic Accuracy Studies‐2 criteria were used to assess the quality of the included studies. Thirteen studies were ranked as having a high or unclear risk of bias in patient selection. All studies were rated as having a low risk of bias in the reference standard and the flow and timing domains. The overall quality assessment is presented in Supplementary Table 1.
Figs 2 and 3 show pooled estimates of the sensitivity and specificity of WLI and LCI in the endoscopic diagnosis of H. pylori infection. The pooled sensitivity values of WLI and LCI for diagnosing H. pylori infection were 0.528 (95% CI, 0.517 to 0.540) and 0.816 (95% CI, 0.790 to 0.841), respectively. The pooled specificity values of WLI and LCI were 0.821 (95% CI, 0.811 to 0.830) and 0.868 (95% CI, 0.850 to 0.884), respectively. The pooled diagnostic odds ratios of WLI and LCI were 15.447 (95% CI, 8.225 to 29.013) and 31.838 (95% CI, 15.576 to 65.078), respectively. The summary receiver operator characteristic curves showed that the derived AUC of WLI and LCI for diagnosing H. pylori infection were 0.870 and 0.911, respectively, and the difference was statistically significant (p<0.001) (Fig. 4).
To directly compare the sensitivity and specificity of WLI and LCI, we used paired data from six studies that both WLI and LCI were conducted on the same patients.11,20,41,43,48,53 The pooled sensitivity of LCI was significantly higher than that of WLI (0.818 [95% CI, 0.790 to 0.845] vs 0.651 [95% CI, 0.618 to 0.685], p<0.001). The pooled specificity was also significantly higher for LCI compared to WLI (0.848 [95% CI, 0.828 to 0.867] vs 0.785 [95% CI, 0.762 to 0.807], p<0.001) (Fig. 5).
Table 2 lists the results of the univariate meta-regression analysis for determining potential factors of heterogeneity. In studies evaluating WLI, the location of the study was analyzed as a probable source of heterogeneity. The study year was divided into before and after/during 2002, which is the year that high-definition endoscopy began to be used, which did not result in significant heterogeneity. For index tests, endoscopic diagnosis was divided into diagnoses based on single findings or on comprehensive criteria, and this did not result in significant heterogeneity. In studies evaluating LCI, all studies were conducted in Asia and in 2016 or later. We could not identify any factors that were a possible source of heterogeneity.
Table 2 . Univariate Meta-Regression Analysis for Identifying Potential Factors of Heterogeneity.
Variable | Coefficient | p-value |
---|---|---|
Studies evaluating WLI (n=32) | ||
Study year (after or during 2002 vs before 2002) | –1.039 | 0.359 |
Study location (Asia vs non-Asia) | 1.449 | 0.043 |
No. of patients (≥145 vs <145) | 1.155 | 0.111 |
Study population (adult vs children) | –1.088 | 0.217 |
Prevalence of HP infection (≥46.7% vs <46.7%) | 0.197 | 0.791 |
Reference standard (single testing vs multiple testing) | 0.955 | 0.388 |
Endoscopic diagnosis (based on single finding(s) vs comprehensive diagnosis) | 0.711 | 0.355 |
Studies evaluating LCI (n=8) | ||
No. of patients (≥119 vs <119) | 1.585 | 0.088 |
Prevalence of HP infection (≥36.25% vs <36.25%) | 0.295 | 0.797 |
Endoscopic diagnosis (based on single finding(s) vs comprehensive diagnosis) | –0.086 | 0.944 |
WLI, white light imaging; HP, Helicobacter pylori; LCI, linked color imaging..
Table 3 presents the results of the subgroup analysis. Comparing the diagnostic performance of WLI according to study location, the pooled sensitivity values were 0.828 (95% CI, 0.814 to 0.841) in 17 Asian studies and 0.311 (95% CI, 0.297 to 0.325) in 15 non-Asian studies. Meanwhile, the pooled specificity values were 0.845 (95% CI, 0.833 to 0.857) and 0.795 (95% CI, 0.781 to 0.809) in Asian and non-Asian studies, respectively.
Table 3 . Subgroup Analysis for the Diagnostic Performance of WLI and LCI.
Variable | No. of studies | Sensitivity (95% CI) | Specificity (95% CI) | Diagnostic OR (95% CI) |
---|---|---|---|---|
Studies evaluating WLI (n=32) | ||||
Study year | ||||
After or during 2002 | 28 | 0.527 (0.515–0.538) | 0.823 (0.814–0.833) | 17.569 (8.922–34.596) |
Before 2002 | 4 | 0.568 (0.510–0.624) | 0.753 (0.696–0.804) | 5.929 (1.024–34.342) |
Study location | ||||
Asia | 17 | 0.828 (0.814–0.841) | 0.845 (0.833–0.857) | 29.355 (13.734–62.744) |
Non-Asia | 15 | 0.311 (0.297–0.325) | 0.795 (0.781–0.809) | 6.724 (3.263–13.858) |
No. of patients | ||||
≥145 | 16 | 0.515 (0.503–0.528) | 0.834 (0.824–0.844) | 27.207 (10.439–70.910) |
<145 | 16 | 0.578 (0.553–0.603) | 0.772 (0.750–0.793) | 7.957 (3.794–16.686) |
Study population | ||||
Adult | 24 | 0.514 (0.503–0.526) | 0.810 (0.799–0.820) | 12.069 (6.105–23.859) |
Children | 8 | 0.729 (0.687–0.768) | 0.892 (0.869–0.911) | 35.657 (5.708–222.75) |
Prevalence of HP infection | ||||
≥46.7% | 16 | 0.491 (0.478–0.504) | 0.840 (0.827–0.853) | 17.748 (6.198–50.825) |
<46.7% | 16 | 0.646 (0.624–0.669) | 0.803 (0.789–0.816) | 13.598 (6.102–30.301) |
Reference standard | ||||
Single testing | 4 | 0.597 (0.520–0.661) | 0.819 (0.769–0.862) | 6.884 (1.264–37.475) |
Multiple testing | 28 | 0.527 (0.515–0.538) | 0.821 (0.811–0.830) | 17.432 (8.821–34.449) |
Endoscopic diagnosis | ||||
Based on single finding(s) | 17 | 0.435 (0.422–0.449) | 0.867 (0.856–0.878) | 21.703 (7.255–64.924) |
Comprehensive diagnosis | 15 | 0.732 (0.714–0.750) | 0.757 (0.741–0.773) | 10.812 (5.019–23.295) |
Studies evaluating LCI (n=8) | ||||
No. of patients | ||||
≥119 | 4 | 0.870 (0.839–0.897) | 0.893 (0.871–0.912) | 67.727 (29.385–156.10) |
<119 | 4 | 0.731 (0.681–0.776) | 0.828 (0.795–0.857) | 14.976 (6.904–32.487) |
Prevalence | ||||
≥36.25% | 4 | 0.793 (0.752–0.830) | 0.864 (0.833–0.891) | 33.296 (15.983–69.363) |
<36.25% | 4 | 0.838 (0.802–0.870) | 0.870 (0.847–0.890) | 34.508 (7.975–149.31) |
Endoscopic diagnosis | ||||
Based on single finding(s) | 3 | 0.874 (0.823–0.916) | 0.817 (0.765–0.862) | 28.734 (10.766–76.692) |
Comprehensive diagnosis | 5 | 0.799 (0.767–0.828) | 0.878 (0.859–0.895) | 35.563 (12.868–98.284) |
WLI, white light imaging; LCI, linked color imaging; OR, odds ratio; CI, confidence interval; HP, Helicobacter pylori..
Our meta-analysis showed that LCI was more sensitive than WLI in the endoscopic diagnosis of H. pylori infection, with a pooled sensitivity of 0.816 compared to 0.528 for WLI. Redness of the fundus gland mucosa, mucosal edema, mucosal nodularity, mucus lake turbidity, rugal hypertrophy, loss of RAC of collecting venules, and hemorrhagic spots are all markers for diagnosing H. pylori gastritis.6 Since LCI enhances color contrast, it facilitates the identification of these typical endoscopic findings.14,15,54 Moreover, under LCI, H. pylori-infected mucosa appeared deep red (crimson) in color, while H. pylori-negative mucosa (past infection or uninfected patients) could clearly be observed as apricot in color, which could be detected better because of distinctive color differences.11,13,41 Dohi et al.11 showed that LCI improved the endoscopic diagnosis of active H. pylori infections, with 10% to 15% improvements in accuracy, sensitivity, and specificity over WLI. In a multicenter prospective study reported by Ono et al.41 comparing the accuracy of LCI and WLI for the endoscopic diagnosis of H. pylori gastritis, LCI was found to be significantly more accurate than WLI in patients with past infections. Our meta-analysis also demonstrated that the LCI patterns are more sensitive than the WLI patterns in diagnosing H. pylori infection, suggesting that LCI can compensate for the low sensitivity of WLI.
When typical endoscopic findings such as mucosal nodularity or mucosal swelling appear, the accuracy of endoscopic diagnosis of H. pylori infection is very high, even under WLI.8 However, in the absence of these typical findings, considerable knowledge and experience may be needed to accurately determine the presence or absence of infection. Our subgroup analysis also identified that the sensitivity of diagnosis was higher in Asian countries than in non-Asian countries. These suggest that high incidence of H. pylori infection and rich experience in endoscopic diagnosis may play an important role in endoscopic diagnosis of H. pylori infection. However, when analyzing the results of six Asian studies that assessed the performance of both WLI and LCI in endoscopic diagnosis of H. pylori infection in the same population, LCI was superior to WLI in both sensitivity and specificity (sensitivity, 0.818 vs 0.651; specificity, 0.848 vs 0.785). In mass screening for gastric cancer and precursor H. pylori gastritis, screening endoscopy with high sensitivity and specificity for endoscopic diagnosis of H. pylori infection might have a significant impact on reducing gastric cancer-related morbidity and mortality. Image-enhanced endoscopy with LCI is expected to play an important role in screening for H. pylori gastritis.
Image-enhanced endoscopy presents images through filtering of illuminating light and/or computing captured electrical images. Narrow-band imaging (NBI; Olympus, Tokyo, Japan) is the most widely used and studied method for the detection of gastrointestinal lesions. Several retrospective studies have shown that NBI is useful in diagnosing H. pylori infection. Alaboudy et al.55 retrospectively assessed H. pylori-infected gastric mucosa, and they classified mucosal patterns into five categories. The classification was found to be well-correlated with histopathological grades of H. pylori gastritis. Tongtawee et al.56 assessed the NBI-based classification system developed by Alaboudy et al.55 and found that types 3, 4, and 5 all had both sensitivity and specificity over 90% for predicting H. pylori positivity. However, a prospective multicenter study for the real-time use of NBI in the diagnosis of gastric lesions including H. pylori gastritis found that the diagnostic accuracy on H. pylori gastritis of WLI and NBI was similar.57 Data are scarce on the diagnostic accuracy of i-scan, another digital image enhancement technique (Pentax Medical, Tokyo, Japan), in diagnosing H. pylori infection. One pilot study has investigated the diagnostic accuracy of i-scan, which showed better diagnostic accuracy of i-scan over conventional WLI in diagnosing H. pylori infection.58
The utility of LCI compared to other image-enhanced techniques is that it can be easily applied in screening endoscopy. NBI is useful in the characterization of known localized lesions, but it may not be appropriate for screening endoscopy, because the light intensity is insufficient to inspect the stomach from a distant view. By contrast, images produced by LCI are brighter and the color contrast is clearer than WLI.59 LCI can observe the entire gastric mucosa with bright images, so it is considered to be a useful tool for diagnosing diffuse gastric lesions such as H. pylori-associated gastritis. Therefore, LCI could be a good screening tool for the real-time diagnosis of H. pylori infection. The routine use of LCI in screening endoscopy would provide valuable information on H. pylori infection status that cannot be obtained using conventional WLI alone.
Magnifying NBI may also be helpful for the endoscopic diagnosis of H. pylori infection. Yagi et al.60 reported that magnifying NBI can detect the RAC of collecting venules in H. pylori-negative normal stomachs. Abnormal mucosal patterns without RAC which were classified as Z-1 to Z-3 were considered as characteristics of H. pylori-infected stomach in magnifying NBI.61 However, magnifying NBI may not be widely used in clinical practice because it takes more time for inspection and has a long learning curve.31
AI will be the trend of future diagnostic technology. However, since our meta-analysis aimed to compare the performance of WLI and LCI, our study intentionally excluded AI-related studies from the analysis. There have already been several systematic reviews and meta-analyses related to AI for endoscopic diagnosis of H. pylori infection recently. In a meta-analysis published in 2020, the performance of AI was superior to endoscopists in the prediction of H. pylori infection (AUC, 0.90 vs 0.82; p<0.001).62 In another meta-analysis published in the same year, pooled sensitivity, specificity, and AUC of AI for the diagnosis of H. pylori infection were 0.87 (95% CI, 0.72 to 0.94), 0.86 (95% CI, 0.77 to 0.92), and 0.92 (95% CI, 0.90 to 0.94).63 A new meta-analysis was published in 2022, and the pooled accuracy was 79.6% (95% CI, 66.7 to 90.0) with a significant heterogeneity (I2=97.9%; 95% CI, 97.2 to 98.6).64 AI-related studies for the diagnosis of H. pylori infection are expected to continue in the future, and good results are expected.
The limitations of this study are as follows. First, significant heterogeneity was found in the pooled estimates of each diagnostic testing. Heterogeneity is a common issue reported in systematic reviews of studies on diagnostic test accuracy.65 Although we identified possible sources of heterogeneity through meta-regression analysis, this heterogeneity was not resolved in the subgroup analysis. The criteria for the endoscopic diagnosis of H. pylori infection in the included studies were all different, which may have contributed substantially to the heterogeneity of the pooled estimates. Second, publication bias was not assessed. Because there are no reliable methods for assessing publication bias in diagnostic test accuracy studies,66 this issue is considered insurmountable. Third, in the quality assessment of the included studies, more than one-third of studies (13 of 34 studies) rated a high or unclear risk of bias in the patient selection domain. This was because these studies were retrospective and did not specify whether or not to enroll patients consecutively. Fourth, since various endoscopic characteristics must be comprehensively judged for endoscopic diagnosis, inter-observer bias exists in these studies. Although there have been many individual studies, the endoscopic features of current H. pylori infection using LCI are not yet well standardized. Recently, to compensate for these limitations, a computer-aided diagnostic system for diagnosing H. pylori infection status using LCI has been developed, and it has shown good results.62-64,67-69 AI technology with IEE is likely to become a useful image diagnostic tool in the future. In order to better utilize the AI-based LCI, we should focus on the color variations of gastric mucosa and create sophisticated diagnostic algorithms in machine-learning system. Finally, all studies evaluating LCI were conducted in Asia. In the future, non-Asian studies on LCI need to be conducted for better meta-analysis.
In summary, this is the first meta-analysis study to evaluate the overall diagnostic ability of conventional WLI and LCI in the endoscopic diagnosis of H. pylori infection. This study revealed that LCI could be useful as a diagnostic tool for H. pylori infection. LCI can provide additional diagnostic ability to conventional endoscopy for H. pylori gastritis, and it could be an effective and convenient tool for detecting and monitoring H. pylori infection in clinical practice. We believe that prospective large-scale studies, especially in non-Asian countries, are needed to validate the effectiveness of LCI in diagnosing H. pylori gastritis. Further using a combination of image-enhanced endoscopy technology with AI could improve the diagnostic accuracy in the future.
This research was supported by Korean Gastrointestinal Endoscopy Research Foundation, 2022 (6H220301001S000100).
No potential conflict of interest relevant to this article was reported.
Study concept and design: S.P.L. Data acquisition: J.G.L., I.K.Y. Data analysis and interpretation: S.P.L., J.G.L., I.K.Y. Drafting of the manuscript: S.P.L., J.G.L., I.K.Y. Critical revision of the manuscript for important intellectual content: A.O.Y. Statistical analysis: J.G.L. Obtained funding: S.P.L. Administrative, technical, or material support; study supervision: S.P.L. Approval of final manuscript: all authors.
Supplementary materials can be accessed at https://doi.org/10.5009/gnl230244.
Table 1 Characteristics of the Included Studies
Study | Country | No. of patients | Prevalence of HP infection | Population | Reference standard | Index test |
---|---|---|---|---|---|---|
Studies evaluating WLI (n=32) | ||||||
Adu-Aryee et al. (2016)24 | Ghana | 76 | 51.3 | Adult | RUT | Comprehensive |
Bah et al. (1995)25 | Switzerland | 86 | 46.5 | Adult | RUT, histology | Comprehensive |
Cho et al. (2013)26 | Korea | 617 | 58.2 | Adult | RUT, histology | Comprehensive |
Cho et al. (2021)27 | Korea | 254 | 64.2 | Adult | RUT, molecular test | Comprehensive |
Dohi et al. (2016)11 | Japan | 60 | 50.0 | Adult | RUT, histology, serology, UBT | Single finding(s) |
Emami et al. (2007)28 | Iran | 501 | 65.1 | Adult | RUT, histology | Single finding(s) |
Fiuza et al. (2021)29 | Brazil | 187 | 25.1 | Adult | RUT, histology | Single finding(s) |
Garcés-Durán et al. (2019)30 | Spain | 140 | 31.4 | Adult | RUT, histology | Single finding(s) |
Gonen et al. (2009)31 | Turkey | 129 | 76.0 | Adult | RUT, histology, UBT | Single finding(s) |
Hidaka et al. (2010)32 | Japan | 87 | 28.7 | Children | Histology, serology, UBT | Single finding(s) |
Katake et al. (2013)33 | Japan | 723 | 70.5 | Adult | Histology, serology | Single finding(s) |
Laine et al. (1995)34 | US | 52 | 53.8 | Adult | Histology | Single finding(s) |
Łazowska-Przeorek et al. (2015)35 | Poland | 341 | 31.4 | Children | RUT, histology, stool antigen, UBT | Single finding(s) |
Lee et al. (2020)20 | Korea | 100 | 37.0 | Adult | RUT, histology | Comprehensive |
Luzza et al. (2001)36 | Italy | 174 | 48.3 | Children | RUT, histology | Single finding(s) |
Machado et al. (2008)37 | Brazil | 99 | 32.3 | Children | RUT, histology | Single finding(s) |
Matrakool et al. (2016)38 | Thailand | 200 | 66.0 | Adult | RUT, histology | Comprehensive |
Mazigh Mrad et al. (2012)39 | Tunisia | 49 | 71.4 | Children | RUT, histology | Single finding(s) |
Niyasom et al. (2019)40 | Thailand | 48 | 25.0 | Children | RUT, histology | Single finding(s) |
Ono et al. (2020)41 | Japan | 127 | 50.4 | Adult | UBT, serology | Single finding(s) |
Rafeey et al. (2004)42 | Iran | 124 | 46.0 | Children | RUT, histology | Single finding(s) |
Redéen et al. (2003)10 | Sweden | 488 | 40.4 | Adult | RUT, histology | Comprehensive |
Sun et al. (2019)43 | China | 253 | 42.3 | Adult | RUT, histology | Comprehensive |
Tahara et al. (2019)44 | Japan | 163 | 46.9 | Adult | Histology, serology, UBT | Comprehensive |
Tomić et al. (2009)45 | Bosnia | 195 | 20.5 | Children | Histology | Single finding(s) |
Toyoshima et al. (2020)46 | Japan | 265 | 15.8 | Adult | RUT, histology | Single finding(s) |
Wang et al. (2019)47 | China | 103 | 26.2 | Adult | RUT, histology | Comprehensive |
Xiu et al. (2021)48 | China | 392 | 34.4 | Adult | RUT, histology, UBT | Comprehensive |
Yagi et al. (2014)49 | Japan | 56 | 58.9 | Adult | Stool antigen | Comprehensive |
Yan et al. (2010)50 | Taiwan | 112 | 67.9 | Adult | RUT, histology | Comprehensive |
Yela et al. (1997)51 | Spain | 150 | 76.7 | Adult | RUT, histology, tissue culture | Comprehensive |
Zhao et al. (2020)52 | China | 583 | 42.2 | Adult | RUT, UBT | Comprehensive |
Studies evaluating LCI (n=8) | ||||||
Chen et al. (2018)13 | Taiwan | 111 | 27.9 | Adult | RUT, histology, UBT | Single finding(s) |
Dohi et al. (2016)11 | Japan | 60 | 50.0 | Adult | RUT, histology, serology, UBT | Single finding(s) |
Jiang et al. (2019)14 | China | 358 | 35.5 | Adult | RUT, histology, UBT | Comprehensive |
Lee et al. (2020)20 | Korea | 100 | 37.0 | Adult | RUT, histology | Comprehensive |
Ono et al. (2020)41 | Japan | 127 | 50.4 | Adult | UBT, serology | Single finding(s) |
Sun et al. (2019)43 | China | 253 | 42.3 | Adult | RUT, histology | Comprehensive |
Wang et al. (2019)47 | China | 103 | 26.2 | Adult | RUT, histology | Comprehensive |
Xiu et al. (2021)48 | China | 392 | 34.4 | Adult | RUT, histology, UBT | Comprehensive |
HP, Helicobacter pylori; WLI, white light imaging; LCI, linked color imaging; RUT, rapid urease test; UBT, urea breath test.
Table 2 Univariate Meta-Regression Analysis for Identifying Potential Factors of Heterogeneity
Variable | Coefficient | p-value |
---|---|---|
Studies evaluating WLI (n=32) | ||
Study year (after or during 2002 vs before 2002) | –1.039 | 0.359 |
Study location (Asia vs non-Asia) | 1.449 | 0.043 |
No. of patients (≥145 vs <145) | 1.155 | 0.111 |
Study population (adult vs children) | –1.088 | 0.217 |
Prevalence of HP infection (≥46.7% vs <46.7%) | 0.197 | 0.791 |
Reference standard (single testing vs multiple testing) | 0.955 | 0.388 |
Endoscopic diagnosis (based on single finding(s) vs comprehensive diagnosis) | 0.711 | 0.355 |
Studies evaluating LCI (n=8) | ||
No. of patients (≥119 vs <119) | 1.585 | 0.088 |
Prevalence of HP infection (≥36.25% vs <36.25%) | 0.295 | 0.797 |
Endoscopic diagnosis (based on single finding(s) vs comprehensive diagnosis) | –0.086 | 0.944 |
WLI, white light imaging; HP, Helicobacter pylori; LCI, linked color imaging.
Table 3 Subgroup Analysis for the Diagnostic Performance of WLI and LCI
Variable | No. of studies | Sensitivity (95% CI) | Specificity (95% CI) | Diagnostic OR (95% CI) |
---|---|---|---|---|
Studies evaluating WLI (n=32) | ||||
Study year | ||||
After or during 2002 | 28 | 0.527 (0.515–0.538) | 0.823 (0.814–0.833) | 17.569 (8.922–34.596) |
Before 2002 | 4 | 0.568 (0.510–0.624) | 0.753 (0.696–0.804) | 5.929 (1.024–34.342) |
Study location | ||||
Asia | 17 | 0.828 (0.814–0.841) | 0.845 (0.833–0.857) | 29.355 (13.734–62.744) |
Non-Asia | 15 | 0.311 (0.297–0.325) | 0.795 (0.781–0.809) | 6.724 (3.263–13.858) |
No. of patients | ||||
≥145 | 16 | 0.515 (0.503–0.528) | 0.834 (0.824–0.844) | 27.207 (10.439–70.910) |
<145 | 16 | 0.578 (0.553–0.603) | 0.772 (0.750–0.793) | 7.957 (3.794–16.686) |
Study population | ||||
Adult | 24 | 0.514 (0.503–0.526) | 0.810 (0.799–0.820) | 12.069 (6.105–23.859) |
Children | 8 | 0.729 (0.687–0.768) | 0.892 (0.869–0.911) | 35.657 (5.708–222.75) |
Prevalence of HP infection | ||||
≥46.7% | 16 | 0.491 (0.478–0.504) | 0.840 (0.827–0.853) | 17.748 (6.198–50.825) |
<46.7% | 16 | 0.646 (0.624–0.669) | 0.803 (0.789–0.816) | 13.598 (6.102–30.301) |
Reference standard | ||||
Single testing | 4 | 0.597 (0.520–0.661) | 0.819 (0.769–0.862) | 6.884 (1.264–37.475) |
Multiple testing | 28 | 0.527 (0.515–0.538) | 0.821 (0.811–0.830) | 17.432 (8.821–34.449) |
Endoscopic diagnosis | ||||
Based on single finding(s) | 17 | 0.435 (0.422–0.449) | 0.867 (0.856–0.878) | 21.703 (7.255–64.924) |
Comprehensive diagnosis | 15 | 0.732 (0.714–0.750) | 0.757 (0.741–0.773) | 10.812 (5.019–23.295) |
Studies evaluating LCI (n=8) | ||||
No. of patients | ||||
≥119 | 4 | 0.870 (0.839–0.897) | 0.893 (0.871–0.912) | 67.727 (29.385–156.10) |
<119 | 4 | 0.731 (0.681–0.776) | 0.828 (0.795–0.857) | 14.976 (6.904–32.487) |
Prevalence | ||||
≥36.25% | 4 | 0.793 (0.752–0.830) | 0.864 (0.833–0.891) | 33.296 (15.983–69.363) |
<36.25% | 4 | 0.838 (0.802–0.870) | 0.870 (0.847–0.890) | 34.508 (7.975–149.31) |
Endoscopic diagnosis | ||||
Based on single finding(s) | 3 | 0.874 (0.823–0.916) | 0.817 (0.765–0.862) | 28.734 (10.766–76.692) |
Comprehensive diagnosis | 5 | 0.799 (0.767–0.828) | 0.878 (0.859–0.895) | 35.563 (12.868–98.284) |
WLI, white light imaging; LCI, linked color imaging; OR, odds ratio; CI, confidence interval; HP, Helicobacter pylori.